key: cord-0830486-al2gimy9 authors: Gresham, Louise M.; Marzario, Barbara; Dutz, Jan; Kirchhof, Mark G. title: Response to Comment on “An Evidence-Based Guide to SARS-Cov-1 2 Vaccination of Patients on Immunotherapies in Dermatology.” date: 2021-04-17 journal: J Am Acad Dermatol DOI: 10.1016/j.jaad.2021.04.026 sha: 0b84674b473bb98d5badf5d414bc3714366dc286 doc_id: 830486 cord_uid: al2gimy9 nan Patients on Immunotherapies in Dermatology." 2 3 Louise M. Gresham We appreciate the authors' attention to detail in noting that in the study by Cho et Robust memory responses against influenza 70 vaccination in pemphigus patients previously treated with rituximab Effect of ocrelizumab on vaccine responses in 73 patients with multiple sclerosis: The VELOCE study Toward a COVID-19 vaccine strategy for 76 patients with pemphigus on rituximab Demonstration of rebound phenomenon 78 following abrupt withdrawal of the JAK1 inhibitor oclacitinib CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients